NASDAQ:BIOA - Nasdaq - US09077V1008 - Currency: USD
2023 (2023-12-31) | 2022 (2022-12-31) | ||||
---|---|---|---|---|---|
ASSETS | |||||
Current Assets | |||||
Cash Equivalents | 21.64M | 27.64M | |||
Other Current Assets | 3.66M | 386.00K | |||
Total Current Assets | 25.31M | 28.03M | |||
Non-Current Assets | |||||
PPE Net | 518.00K | 374.00K | |||
Investments And Advances | 100.00K | 0.00 | |||
Other Non-Current Assets | 0.00 | 25.00K | |||
Total Non-Current Assets | 618.00K | 399.00K | |||
TOTAL ASSETS | 25.92M | 28.43M | |||
LIABILITIES | |||||
Current Liabilities | |||||
Short Term Debt | 38.86M | 0.00 | |||
Current Portion Of LT Debt. | 6.00M | 167.00K | |||
Accrued Expenses | 6.74M | 3.41M | |||
Accounts Payable | 1.87M | 2.26M | |||
Other Current Liabilities | 4.70M | 24.00K | |||
Total Current Liabilities | 58.17M | 5.86M | |||
Non-Current Liabilities | |||||
Long Term Debt | 8.20M | 2.25M | |||
Other Non-Current Liabilities | 229.00K | 153.00K | |||
Total Non-Current Liabilities | 8.43M | 2.40M | |||
TOTAL LIABILITIES | 66.60M | 8.27M | |||
SHAREHOLDERS' EQUITY | |||||
Retained Earnings | -181.70M | -117.85M | |||
Additional Paid In Capital | 8.14M | 5.12M | |||
Common Shares | 132.72M | 132.72M | |||
Other Shareholders' Equity | 164.00K | 167.00K | |||
Shares Outstanding | 34.17M | 34.17M | |||
Tangible Book Value per Share | -5.07 | -3.29 | |||
Total Shareholders' Equity | -40.67M | 20.16M | |||
TOTAL LIABILITIES AND EQUITY | 25.92M | 28.43M | |||
Statistics | |||||
Debt/Equity | -1.16 | 0.11 | |||
Current Ratio | 0.44 | 4.78 | |||
Return On Assets (ROA) | -246.31% | -139.72% | |||
Return On Equity (ROE) | N/A | -197.00% |
All data in USD , ROIC based on taxRate of 0.21